Does INOTUZUMAB OZOGAMICIN Cause Neoplasm progression? 158 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Neoplasm progression have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 6.8% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
158
Reports of Neoplasm progression with INOTUZUMAB OZOGAMICIN
6.8%
of all INOTUZUMAB OZOGAMICIN reports
104
Deaths
26
Hospitalizations
How Dangerous Is Neoplasm progression From INOTUZUMAB OZOGAMICIN?
Of the 158 reports, 104 (65.8%) resulted in death, 26 (16.5%) required hospitalization, and 8 (5.1%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTUZUMAB OZOGAMICIN. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
Drug ineffective (92)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Neoplasm progression Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC